Literature DB >> 6582587

Physiology and ecology of the vagina.

J Paavonen.   

Abstract

The human vagina is lined by stratified squamous epithelium which has no glands. Major components of the vaginal secretions are transudate through the vaginal walls, desquamating epithelial cells, cervical mucus, fluids from the upper genital tract, and leukocytes. Estrogens and sexual stimulation are examples of factors which increase vaginal fluid. Major organic constituents of the vaginal fluid are proteins, carbohydrates, and fatty acids. Organic acids arise as metabolic byproducts of vaginal bacterial flora, cause the vaginal odor, and show cyclic changes except in oral contraceptive users. Qualitative and quantitative studies in humans as well as animal model studies have confirmed that the vaginal flora is a dynamic and closely interrelated system. Lactobacilli are most prevalent, but many other facultative and anaerobic organisms are present. An inverse relationship exists between the concentration of lactobacilli and other bacteria such as anaerobes. Aerobic bacteria decrease premenstrually whereas anaerobes, in general, remain at constant levels. During menarche, pregnancy, postpartum period, menopause, and postoperative trauma, dramatic changes occur in the microbial flora. The role of an IUD in causing changes in the microbial flora is under great scrutiny at the present time. Overall, disturbances in the vaginal ecosystem may have a potential impact on many diseases, and thus deserve careful studies.

Entities:  

Mesh:

Year:  1983        PMID: 6582587

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  29 in total

1.  Comparison of dermatopharmacokinetic vs. clinicial efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans.

Authors:  Lynn K Pershing; Judy L Corlett; Joel L Nelson
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Defined medium simulating genital tract secretions for growth of vaginal microflora.

Authors:  A M Geshnizgani; A B Onderdonk
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  CsrRS regulates group B Streptococcus virulence gene expression in response to environmental pH: a new perspective on vaccine development.

Authors:  Isabella Santi; Renata Grifantini; Sheng-Mei Jiang; Cecilia Brettoni; Guido Grandi; Michael R Wessels; Marco Soriani
Journal:  J Bacteriol       Date:  2009-06-19       Impact factor: 3.490

4.  The transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure.

Authors:  Stephanie Schielke; Corinna Schmitt; Carolin Spatz; Matthias Frosch; Alexandra Schubert-Unkmeir; Oliver Kurzai
Journal:  Appl Environ Microbiol       Date:  2010-03-26       Impact factor: 4.792

Review 5.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.

Authors:  Paria Mirmonsef; Laurie Krass; Alan Landay; Gregory T Spear
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

6.  [Bacteriology of vaginal flora].

Authors:  H Hahn; C H Coester
Journal:  Arch Gynecol       Date:  1985

7.  Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components.

Authors:  G S Tamura; J M Kuypers; S Smith; H Raff; C E Rubens
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Mixed-effect models for predicting microbial interactions in the vaginal ecosystem.

Authors:  R A Ross; M L Lee; M L Delaney; A B Onderdonk
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification.

Authors:  E R Boskey; K M Telsch; K J Whaley; T R Moench; R A Cone
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

Review 10.  The changing landscape of the vaginal microbiome.

Authors:  Bernice Huang; Jennifer M Fettweis; J Paul Brooks; Kimberly K Jefferson; Gregory A Buck
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.